ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 134 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $131,153 | -97.4% | 14,099 | -97.2% | 0.00% | -100.0% |
| Q1 2024 | $5,007,336 | +977.1% | 506,286 | +251.7% | 0.00% | – |
| Q4 2023 | $464,910 | -39.2% | 143,935 | 0.0% | 0.00% | -100.0% |
| Q3 2023 | $764,295 | -44.6% | 143,935 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $1,380,087 | +3.2% | 144,815 | +19.2% | 0.00% | -50.0% |
| Q1 2023 | $1,336,885 | -28.1% | 121,535 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $1,860,648 | -25.6% | 125,821 | -3.8% | 0.00% | -50.0% |
| Q3 2022 | $2,501,000 | +5.0% | 130,724 | +17.0% | 0.00% | +33.3% |
| Q2 2022 | $2,383,000 | +34.4% | 111,757 | +21.5% | 0.00% | +50.0% |
| Q1 2022 | $1,773,000 | +118.9% | 91,988 | +166.5% | 0.00% | +100.0% |
| Q4 2021 | $810,000 | +217.6% | 34,523 | +283.2% | 0.00% | – |
| Q4 2020 | $255,000 | – | 9,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $305,003,000 | 24.46% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $115,121,000 | 6.52% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $16,462,000 | 5.28% |
| SECTORAL ASSET MANAGEMENT INC | 878,948 | $25,428,000 | 1.93% |
| Omega Fund Management, LLC | 623,836 | $18,048,000 | 1.71% |
| Orbimed Advisors | 6,073,850 | $175,716,000 | 1.64% |
| Altium Capital Management LP | 113,962 | $3,297,000 | 0.92% |
| Vivo Capital, LLC | 744,370 | $21,535,000 | 0.76% |
| Polar Capital Holdings Plc | 1,557,543 | $45,060,000 | 0.28% |
| Birchview Capital, LP | 9,000 | $260,000 | 0.15% |